Trial intelligence / Profile preview

Cetuximab and FOLFIRI in Metastatic Colorectal Cancer (DERMATUX)

NCT01315990Phase 4Unknown

Start
Jan 2011
Primary completion
Mar 2015
Countries
1
01

Overview

Phase 4, open-label trial of KL-140 in metastatic colorectal cancer (mCRC). Status: unknown.

02

Drugs

KL-140
03

Conditions

metastatic colorectal cancer (mCRC)

Beyond the preview

Go deeper on NCT01315990.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01315990.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call